Making a Difference – The Business of Rare Disease Drug Development
Drug development designed to treat rare disease is both a noble cause and a risky business. Rare diseases are typically deadly, debilitating, and devastating for…
Pharma
Defying the Odds: Speeding Patient Access to Life-Changing Treatments in Rare Disease
To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and engaging more deeply with physicians and experts….
How AI is Transforming the Future of Cancer Medical Treatment
How AI is advancing and transforming future cancer medical treatments and how a cure for cancer may be closer than we think. AI is transforming…
Next-gen Medical Education Technologies to Keep an Eye on in 2025
While opportunities for continuing education and Pharma-sponsored learning programs are always welcome by healthcare providers (HCPs), it is no secret that traditional HCP education is…
Six Trends Shaping Patient-centric Pharmaceutical Logistics in 2025
Delphine Perridy, Chief Commercial Officer at Envirotainer explores six essential predictions shaping pharmaceutical logistics and cold chain for the year ahead. The pharmaceutical cold chain…
Balancing Innovation and Clinical Trial Efficiency – Is there a Middle Ground?
To advance science without compromising trial efficiency, we must prioritise simpler user journeys and connected data. Clinical trials are constantly pushing the boundaries of innovation….
Transforming Clinical Trials with Digital Platforms for Patient Recruitment
Patient recruitment is a crucial element in clinical trials, often determining their success. Traditional recruitment methods face significant challenges, leading to delays and incomplete studies….
AI-Powered Precision Measures: A Golden Opportunity for Clinical Research
As the cost of developing new therapies continues to rise, pharma executives must turn to technologies that drive better insights into de-risked investments and produce…
How Connected Cloud-based Platforms are Advancing Quality in Biopharma Manufacturing
Robert Gaertner, Vice President of Quality Strategy Europe at Veeva Systems, discusses the growing importance of connected platforms in ensuring quality in pharmaceutical manufacturing and…
Democratising Access to Clinical Trials Across the EU
Winston Churchill once famously said; “Healthy citizens are the greatest asset any country can have.” The importance of a healthy population is why we see…